ZA959417B - Production of peptides which are analogues of hydrophobic peptides recombinant peptide corresponding DNA sequence - Google Patents
Production of peptides which are analogues of hydrophobic peptides recombinant peptide corresponding DNA sequenceInfo
- Publication number
- ZA959417B ZA959417B ZA959417A ZA959417A ZA959417B ZA 959417 B ZA959417 B ZA 959417B ZA 959417 A ZA959417 A ZA 959417A ZA 959417 A ZA959417 A ZA 959417A ZA 959417 B ZA959417 B ZA 959417B
- Authority
- ZA
- South Africa
- Prior art keywords
- peptides
- analogues
- production
- dna sequence
- corresponding dna
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title 3
- 102000004196 processed proteins & peptides Human genes 0.000 title 2
- 108091028043 Nucleic acid sequence Proteins 0.000 title 1
- 230000002209 hydrophobic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9413307A FR2726576B1 (en) | 1994-11-07 | 1994-11-07 | PRODUCTION OF HYDROPHOBIC PEPTIDE-LIKE PEPTIDES, RECOMBINANT PEPTIDE, CORRESPONDING DNA SEQUENCE |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA959417B true ZA959417B (en) | 1996-06-11 |
Family
ID=9468565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA959417A ZA959417B (en) | 1994-11-07 | 1995-11-07 | Production of peptides which are analogues of hydrophobic peptides recombinant peptide corresponding DNA sequence |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0791059A1 (en) |
JP (1) | JPH10508479A (en) |
AU (1) | AU704594B2 (en) |
CA (1) | CA2204511A1 (en) |
FR (1) | FR2726576B1 (en) |
NZ (1) | NZ296562A (en) |
WO (1) | WO1996014409A1 (en) |
ZA (1) | ZA959417B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5789653A (en) * | 1995-01-10 | 1998-08-04 | University Of Edinburgh | Secretory gene trap |
GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
AUPO026596A0 (en) * | 1996-06-05 | 1996-06-27 | Biomolecular Research Institute Limited | Viral peptide |
FR2766192B1 (en) * | 1997-07-17 | 2001-07-13 | Pf Medicament | EPITOPES OF RSV AND ANTIBODIES COMPRISING SAME, USEFUL IN DIAGNOSIS AND THERAPY |
EP1276756A4 (en) | 2000-04-12 | 2004-06-09 | Human Genome Sciences Inc | Albumin fusion proteins |
FR2819810B1 (en) * | 2001-01-23 | 2004-05-28 | Pf Medicament | NON-GLYCOSYL PEPTIDES DERIVED FROM RSV PROTEIN G AND THEIR USE IN A VACCINE |
US7507413B2 (en) | 2001-04-12 | 2009-03-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
ES2545090T3 (en) | 2001-12-21 | 2015-09-08 | Human Genome Sciences, Inc. | Albumin and GCSF fusion proteins |
WO2015120541A1 (en) * | 2014-02-14 | 2015-08-20 | Symvivo Corporation | Nucleic acid vectors and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01501357A (en) * | 1986-01-14 | 1989-05-18 | ユニバ−シテイ・オブ・ノ−ス・カロライナ | Vaccines for human respiratory viruses |
US4734362A (en) * | 1986-02-03 | 1988-03-29 | Cambridge Bioscience Corporation | Process for purifying recombinant proteins, and products thereof |
US4925784A (en) * | 1986-04-04 | 1990-05-15 | Hoffmann-La Roche Inc. | Expression and purification of an HTLV-III gag/env gene protein |
EP0249477A3 (en) * | 1986-06-12 | 1988-01-20 | Immunex Corporation | Functional recombinant analog polypeptides devoid of hydrophobic amino acids |
US5223254A (en) * | 1987-09-29 | 1993-06-29 | Praxis Biologics, Inc. | Respiratory syncytial virus: vaccines |
ES2176174T3 (en) * | 1988-12-22 | 2002-12-01 | Genentech Inc | PROCEDURE FOR PREPARATION OF WATER SOLUBLE POLYPEPTIDES. |
-
1994
- 1994-11-07 FR FR9413307A patent/FR2726576B1/en not_active Expired - Fee Related
-
1995
- 1995-11-07 EP EP95939336A patent/EP0791059A1/en not_active Withdrawn
- 1995-11-07 CA CA002204511A patent/CA2204511A1/en not_active Abandoned
- 1995-11-07 JP JP8515108A patent/JPH10508479A/en active Pending
- 1995-11-07 NZ NZ296562A patent/NZ296562A/en unknown
- 1995-11-07 ZA ZA959417A patent/ZA959417B/en unknown
- 1995-11-07 WO PCT/FR1995/001464 patent/WO1996014409A1/en not_active Application Discontinuation
- 1995-11-07 AU AU41200/96A patent/AU704594B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
FR2726576B1 (en) | 1997-01-31 |
FR2726576A1 (en) | 1996-05-10 |
NZ296562A (en) | 1999-11-29 |
EP0791059A1 (en) | 1997-08-27 |
WO1996014409A1 (en) | 1996-05-17 |
AU704594B2 (en) | 1999-04-29 |
AU4120096A (en) | 1996-05-31 |
JPH10508479A (en) | 1998-08-25 |
CA2204511A1 (en) | 1996-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL146093A0 (en) | Method of separating a polypeptide or protein from a solution containing a plurality thereof | |
IL205233A0 (en) | A polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive, or a fragment or trunaction thereof | |
HUP9901455A3 (en) | Somatostatin peptides | |
IL121520A (en) | Polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive or a fragment or truncation thereof | |
EP2327775A3 (en) | Therapy for alpha-galactosidase a deficiency | |
DE69332485D1 (en) | Immunomodulatory peptides | |
EP1619202A3 (en) | immunotherapeutic methods using epitopes of wt-1 and gata-1 | |
AU3321595A (en) | Recombinant production of biologically active peptides and proteins | |
HUP9802372A3 (en) | Cyclic peptide analogs of somatostatin | |
GB9126329D0 (en) | Opioid peptides derived from wheat proteins | |
AU4415796A (en) | Production of c-terminal amidated peptides from recombinant protein constructs | |
ZA861482B (en) | Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known | |
ZA959417B (en) | Production of peptides which are analogues of hydrophobic peptides recombinant peptide corresponding DNA sequence | |
HUP9903961A3 (en) | Tripeptide intermediates of antithrombotic azacycloalkylalkanoyl peptides | |
AU5635896A (en) | Recombinant endotoxin-neutralizing proteins | |
AU1884297A (en) | Recombinant protein containing a c-terminal fragment of plasmodium msp-1 | |
IL116973A0 (en) | Extraction of recombinant proteins | |
GB9714680D0 (en) | Recombinant production of proteins | |
IL122412A0 (en) | Recombinant viral nucleic acids | |
DE69427363D1 (en) | Platelet-inhibiting peptides | |
NZ273815A (en) | Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides | |
GB9703802D0 (en) | Anti-hiv peptides and proteins | |
GB9714681D0 (en) | Recombinant production of proteins | |
EP0744467A3 (en) | Multiple antigenic peptide comprising at least two hepatitis C virus-associated peptides | |
AU4410689A (en) | Method for sequencing peptides or proteins |